Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement published in Financial Express (English) and Vishwavani (Kannada) today, relating to audited financial results for quarter and financial year ended March 31, 2024. Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46(2)(o) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Q4FY24 earnings call, conducted on May 30, 2024, is given below. FY24 Annual Result Announced for Indegene Ltd.
Consulting Services company Indegene announced FY24 results: FY24 Revenue up by 12.3% YoY, crosses Rs 2,500 crore FY24 EBITDA up 28.6%, and PAT up by 26.5% Yoy FY24 EBITDA% up by 286 bps, and PAT% up by 146 bps YoY Manish Gupta, Chairman and Chief Executive Officer - "We are pleased with our continued performance this quarter and the full year. Today in the marketplace we are known as a digital first commercialization partner to the global life sciences industry. We have 63 active clients and work with all the top 20 global pharmaceutical companies. Our revenues very closely mirrors the global life sciences industry's spends on operations. 69% of our revenues come from the top 20 Pharma companies. Global Life Sciences industry is more than USD 1.8 Tn Industry. We are excited about the opportunity in front of us." Suhas Prabhu, Chief Financial Officer - "Our financial results reflect our focus on operational excellence, cost optimization and value-driven service delivery. While revenue grew steadily, we delivered strong growth in margins, with a healthy cash conversion and a strong balance sheet, providing us with the flexibility to invest in growth opportunities. We remain committed to delivering value to our clients and shareholders through deep domain expertise, innovation and operational excellence." Result PDF Indegene Ltd - 544172 - Intimation Of Outcome Of Board Meeting
Audited Standalone and Audited Consolidated Financial Results alongwith Auditor''s Report for the quarter and financial year ended March 31, 2024 Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Investor Presentation
Updated Fact Sheet - Consolidated Financial Data - for the quarter and financial year ended March 31, 2024 Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Investor Presentation
Fact Sheet - Consolidated Financial Data - for the quarter and financial year ended March 31, 2024 Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We wish to inform you that the Company has made a press release dated May 29, 2024, announcing the financial results for the quarter and financial year end March 31, 2024, as approved by the Board of Directors at its meeting on May 29, 2024 (VIA AUDIO/VIDEO MODE) Indegene Ltd - 544172 - Board Meeting Outcome for Indegene Limited Has Informed The Exchange Regarding Board Meeting Held On May 29, 2024.
Audited Standalone and Consolidated Financial Results along with Auditor's Report thereon for the quarter and financial year ended March 31, 2024. The Financial Results along with the Auditors' Report with an unmodified opinion are attached herewith. Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Indegene Q4FY24 Earnings Call Indegene Ltd - 544172 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter And Financial Year Ended March 31, 2024
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve 1. The audited consolidated financial results and statements of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter and financial year ending March 31, 2024 along with the reports of the Auditors thereon; 2. The audited standalone financial results and statements of the Company as per INDAS for the quarter and financial year ending March 31, 2024 along with the reports of the Auditors thereon;